Cocrystal Pharma COCP
NASDAQ COCP
$0.96 +0.02 (+1.81%)
As of: Oct 21, 2026 · 3:20 PM EDT

Cocrystal Pharma (COCP) FCF Margin (2013 - 2026)

Updated

Cocrystal Pharma (COCP) reported FCF Margin of -2396.19% for Q2 2026, down 1356.19 percentage points from the prior quarter.

Analysis

Cocrystal Pharma (COCP) FCF Margin (2013 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Cocrystal Pharma's FCF Margin came in at -599.10%; for FY2020, it was -500.00%, down 473.98 percentage points from FY2019.

  • By year, FCF Margin came in at -26.02% in FY2019.
  • The Q2 2026 figure ranks as the lowest quarterly FCF Margin in data going back to Q1 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 33.76%
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 28.82%
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 18.33%
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 26.96%
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 38.60%
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 6.55%
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 34.70%
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 44.00%
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 2.01%
10 Cocrystal Pharma 13.24 Mn -8.67 Mn - -2,396.19%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2,396.19%
Mar 31, 2026 -1,040.00%
Dec 31, 2020 -467.06%
Sep 30, 2020 -629.86%
Jun 30, 2020 -420.04%
Mar 31, 2020 -494.79%
Dec 31, 2019 -306.22%
Sep 30, 2019 -292.28%
Jun 30, 2019 -174.32%
Mar 31, 2019 39.25%
Mar 31, 2018 -2,814.86%
Sep 30, 2016 -6,194.12%
Jun 30, 2016 -13,292.31%
Mar 31, 2016 -8,285.71%
Jun 30, 2013 -68,258.60%
API Access

Cocrystal Pharma FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=COCP&period=max&api_key=YOUR_API_KEY